I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| goblet cell | 3 studies | 31% ± 18% | |
| epithelial cell | 3 studies | 20% ± 3% | |
| astrocyte | 3 studies | 23% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| goblet cell | 3 studies | 31% ± 18% | |
| epithelial cell | 3 studies | 20% ± 3% | |
| astrocyte | 3 studies | 23% ± 9% |
Insufficient scRNA-seq data for expression of B3GALT5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 1022.93 | 328 / 328 | 93% | 16.67 | 166 / 178 |
| intestine | 90% | 3352.99 | 873 / 966 | 78% | 8.11 | 413 / 527 |
| brain | 68% | 481.75 | 1806 / 2642 | 53% | 1.11 | 377 / 705 |
| thymus | 93% | 520.23 | 609 / 653 | 28% | 0.84 | 172 / 605 |
| stomach | 50% | 307.17 | 180 / 359 | 70% | 6.39 | 200 / 286 |
| esophagus | 57% | 327.88 | 820 / 1445 | 58% | 5.94 | 106 / 183 |
| breast | 41% | 419.33 | 187 / 459 | 61% | 6.06 | 682 / 1118 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.66 | 1 / 1 |
| bladder | 43% | 201.81 | 9 / 21 | 52% | 3.42 | 264 / 504 |
| ovary | 67% | 212.82 | 121 / 180 | 19% | 0.68 | 82 / 430 |
| uterus | 46% | 213.96 | 79 / 170 | 30% | 2.14 | 136 / 459 |
| skin | 62% | 361.15 | 1130 / 1809 | 2% | 0.07 | 11 / 472 |
| kidney | 22% | 97.24 | 20 / 89 | 40% | 2.35 | 362 / 901 |
| prostate | 43% | 239.61 | 106 / 245 | 12% | 0.25 | 59 / 502 |
| tonsil | 0% | 0 | 0 / 0 | 49% | 3.86 | 22 / 45 |
| adrenal gland | 12% | 28.76 | 30 / 258 | 32% | 1.02 | 74 / 230 |
| lung | 5% | 12.49 | 30 / 578 | 26% | 2.23 | 300 / 1155 |
| liver | 8% | 16.04 | 19 / 226 | 10% | 0.70 | 42 / 406 |
| spleen | 5% | 8.89 | 12 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.05 | 3 / 80 |
| muscle | 3% | 4.62 | 24 / 803 | 0% | 0 | 0 / 0 |
| adipose | 2% | 7.62 | 28 / 1204 | 0% | 0 | 0 / 0 |
| heart | 1% | 2.52 | 7 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.50 | 5 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009312 | Biological process | oligosaccharide biosynthetic process |
| GO_0006629 | Biological process | lipid metabolic process |
| GO_0006493 | Biological process | protein O-linked glycosylation |
| GO_0006486 | Biological process | protein glycosylation |
| GO_0009617 | Biological process | response to bacterium |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0008499 | Molecular function | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | B3GALT5 |
| Protein name | Hexosyltransferase (EC 2.4.1.-) Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) |
| Synonyms | |
| Description | FUNCTION: Catalyzes the transfer of Gal to GlcNAc-based acceptors with a preference for the core3 O-linked glycan GlcNAc(beta1,3)GalNAc structure. Can use glycolipid LC3Cer as an efficient acceptor. . |
| Accessions | ENST00000380620.8 ENST00000682542.1 ENST00000398714 ENST00000684187.2 ENST00000343118.6 ENST00000684495.1 ENST00000380618.5 ENST00000615480.5 A0A0A0MS93 Q9Y2C3 ENST00000683344.1 ENST00000398714.4 |
